Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...

The probability of technical and regulatory success (PTRS) in drug development is around 8% 1. The highest impact is the 36% probability of success in phase 2, impacted by limited efficacy. To ...

Twenty-five years ago, if Jeff Bezos had told me he would become the richest man on Earth while selling books from his garage, I would have laughed in disbelief. Yet here we are—his seemingly ...

Nano One is nearing its first revenue-producing deals, potentially boosting the stock significantly. The company secured a C$15 million loan and a C$3 million grant from the Canadian government.

Source: Getty Images Phase 2 data suggest that metastectomy in renal cell carcinoma may be associated with delayed disease progression and prolonged survival. At 24 weeks after surgery, metastasectomy ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The final quarter of 2023 saw a ...